• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

积液的免疫细胞化学:SCIP方法介绍

Immunocytochemistry of effusion fluids: Introduction to SCIP approach.

作者信息

Shidham Vinod B, Layfield Lester J

机构信息

Department of Pathology, Wayne State University School of Medicine, Karmanos Cancer Center, and Detroit Medical Center, Detroit, Michigan, USA.

Department of Pathology and Anatomical Sciences, University of Missouri, One Hospital Drive, Columbia, Missouri, USA.

出版信息

Cytojournal. 2022 Jan 31;19:3. doi: 10.25259/CMAS_02_05_2021. eCollection 2022.

DOI:10.25259/CMAS_02_05_2021
PMID:35541032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9079320/
Abstract

Due to the remarkably wide morphologic spectrum of reactive mesothelial cells, some of the effusion fluids may be difficult to interpret with objective certainty by cytomorphology alone. Cytomorphology of well to moderately differentiated adenocarcinomas (responsible for the bulk of malignant effusions) may overlap with floridly reactive mesothelial cells. Even mesotheliomas including diffuse malignant epithelioid mesothelioma, are usually cytomorphologically bland without unequivocal features of malignancy. The intensity of challenge depends on the interpreter's training or experience level, institutional demographics of patients (such as type of prevalent diseases, predominant sex and age group), technical support, and quality of cytopreparatory processing. In general immunocytochemistry is valuable adjunct to facilitate objective interpretation with or without other ancillary techniques as indicated. An increasing number of immunomarkers is further refining the contribution of immunohistochemistry to this field. However, application of immunohistochemistry to effusion fluids is relatively challenging because of many variables. Multiple factors such as delay after specimen collection, specimen processing related factors including fixation and storage; ambient conditions under which paraffin blocks are archived (for retrospective testing); antigen retrieval method; duration of antigen retrieval step; antibody clone and dilution; and antibody application time are identical to application of immunohistochemistry in other areas. The significant challenge related to the potential compromization of the immunoreactivity pattern due to exposure to non-formalin fixatives / reagents is also applicable to effusion fluid specimens. The immunoreactivity results would be compared and corelated with cumulative metadata based on the reported studies performed and validated on formalin-fixed paraffin-embedded tissue sections. Deviating from such protocols may lead to suboptimal results, which is not uncommon in clinical practice with potential compromization of patient care and related liability. Because of this, it is critical to perform immunocytochemistry on formalin-fixed cell-block sections only. In addition, unless the interpretation criteria for immunohistochemical evaluation of effusion fluids are not modified specifically, it may not be productive in resolving some challenging cases. However, this aspect is not well elaborated in the literature. A basic and critical challenge is finding and locating the cells of interest in cell-block sections of effusion fluids. A unique approach is to choose a fundamental immunopanel which highlight the mesothelial and inflammatory cells in reactive effusion fluids to create the basic map. This allows detection of a 'second-foreign' population which can be immunocharacterized further with the help of subtractive coordinate immunoreactivity pattern (SCIP) approach elaborated here.

摘要

由于反应性间皮细胞的形态谱极为广泛,仅靠细胞形态学对某些积液进行客观明确的解读可能存在困难。高分化至中分化腺癌(导致大量恶性积液的原因)的细胞形态学可能与活跃反应性间皮细胞重叠。即使是间皮瘤,包括弥漫性恶性上皮样间皮瘤,通常在细胞形态学上也较为平淡,缺乏明确的恶性特征。挑战的程度取决于解读人员的培训或经验水平、患者的机构人口统计学特征(如流行疾病类型、主要性别和年龄组)、技术支持以及细胞制备处理的质量。一般来说,免疫细胞化学是一种有价值的辅助手段,可根据需要与其他辅助技术一起促进客观解读。越来越多的免疫标志物正在进一步完善免疫组织化学在该领域的作用。然而,由于存在许多变量,将免疫组织化学应用于积液相对具有挑战性。多个因素,如标本采集后的延迟、标本处理相关因素(包括固定和储存);石蜡块存档的环境条件(用于回顾性检测);抗原修复方法;抗原修复步骤的持续时间;抗体克隆和稀释度;以及抗体应用时间,与免疫组织化学在其他领域的应用相同。与因接触非福尔马林固定剂/试剂而导致免疫反应模式潜在受损相关的重大挑战也适用于积液标本。免疫反应结果将与基于在福尔马林固定石蜡包埋组织切片上进行并验证的已报道研究的累积元数据进行比较和关联。偏离此类方案可能导致结果不理想,这在临床实践中并不罕见,可能会损害患者护理并带来相关责任。因此,仅对福尔马林固定的细胞块切片进行免疫细胞化学至关重要。此外,除非专门修改积液免疫组织化学评估的解读标准,否则在解决一些具有挑战性的病例时可能无济于事。然而,这方面在文献中并未得到充分阐述。一个基本且关键的挑战是在积液的细胞块切片中找到并定位感兴趣的细胞。一种独特的方法是选择一个基本的免疫组,该免疫组突出反应性积液中的间皮细胞和炎症细胞,以创建基本图谱。这允许检测出一个“第二外来”群体,借助此处阐述的数据坐标免疫反应模式(SCIP)方法可对其进行进一步的免疫特征分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/134ccee14f39/Cytojournal-19-3-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/ed2b78b2f452/Cytojournal-19-3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/70c4d2874b7f/Cytojournal-19-3-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/15d2a397f9aa/Cytojournal-19-3-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/a98b175e2fa6/Cytojournal-19-3-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/eb32f2fb6cee/Cytojournal-19-3-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/732b799a1e15/Cytojournal-19-3-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/f212e598aef8/Cytojournal-19-3-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/7fe913206f44/Cytojournal-19-3-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/5d8c320bbde9/Cytojournal-19-3-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/733cf71ba3a5/Cytojournal-19-3-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/57f651b244de/Cytojournal-19-3-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/d017a7f7b0b9/Cytojournal-19-3-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/3f2d21ab3135/Cytojournal-19-3-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/ecc1bc69da2c/Cytojournal-19-3-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/50992098a485/Cytojournal-19-3-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/9ed3da7de987/Cytojournal-19-3-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/b2c4f3fdb3cd/Cytojournal-19-3-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/81fbb04e2400/Cytojournal-19-3-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/d2d11d38a041/Cytojournal-19-3-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/f1e8d2b60071/Cytojournal-19-3-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/134ccee14f39/Cytojournal-19-3-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/ed2b78b2f452/Cytojournal-19-3-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/70c4d2874b7f/Cytojournal-19-3-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/15d2a397f9aa/Cytojournal-19-3-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/a98b175e2fa6/Cytojournal-19-3-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/eb32f2fb6cee/Cytojournal-19-3-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/732b799a1e15/Cytojournal-19-3-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/f212e598aef8/Cytojournal-19-3-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/7fe913206f44/Cytojournal-19-3-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/5d8c320bbde9/Cytojournal-19-3-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/733cf71ba3a5/Cytojournal-19-3-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/57f651b244de/Cytojournal-19-3-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/d017a7f7b0b9/Cytojournal-19-3-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/3f2d21ab3135/Cytojournal-19-3-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/ecc1bc69da2c/Cytojournal-19-3-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/50992098a485/Cytojournal-19-3-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/9ed3da7de987/Cytojournal-19-3-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/b2c4f3fdb3cd/Cytojournal-19-3-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/81fbb04e2400/Cytojournal-19-3-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/d2d11d38a041/Cytojournal-19-3-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/f1e8d2b60071/Cytojournal-19-3-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90e/9079320/134ccee14f39/Cytojournal-19-3-g021.jpg

相似文献

1
Immunocytochemistry of effusion fluids: Introduction to SCIP approach.积液的免疫细胞化学:SCIP方法介绍
Cytojournal. 2022 Jan 31;19:3. doi: 10.25259/CMAS_02_05_2021. eCollection 2022.
2
Immunocytochemistry of effusions: Processing and commonly used immunomarkers.积液的免疫细胞化学:处理方法及常用免疫标志物
Cytojournal. 2022 Jan 31;19:6. doi: 10.25259/CMAS_02_15_2021. eCollection 2022.
3
Approach to Diagnostic Cytopathology of Serous Effusions.浆液性积液的诊断细胞病理学方法
Cytojournal. 2021 Dec 6;18:32. doi: 10.25259/CMAS_02_03_2021. eCollection 2021.
4
Cell-blocks and immunohistochemistry.细胞块与免疫组织化学。
Cytojournal. 2021 Jan 30;18:2. doi: 10.25259/Cytojournal_83_2020. eCollection 2021.
5
Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?细胞恶性与良性:体液细胞学中“新型”标志物的作用有多大?
Arch Pathol Lab Med. 2008 Jan;132(1):23-8. doi: 10.5858/2008-132-23-CMVBHU.
6
Two-color immunocytochemistry for evaluation of effusion fluids for metastatic adenocarcinoma.用于评估转移性腺癌积液的双色免疫细胞化学法。
Cytojournal. 2010 Feb 10;7:1. doi: 10.4103/1742-6413.59887.
7
Introduction to the second edition of 'Diagnostic Cytopathology of Serous Fluids' as CytoJournal Monograph (CMAS) in Open Access.《浆膜腔积液诊断细胞病理学》第二版作为开放获取的《细胞病理学杂志》专论(CMAS)介绍
Cytojournal. 2021 Dec 6;18:30. doi: 10.25259/CMAS_02_01_2021. eCollection 2021.
8
Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.恶性间皮瘤:免疫组织化学和DNA倍体分析作为鉴别胸膜和腹膜积液中间皮瘤与良性反应性间皮细胞增生及腺癌的方法。
Arch Pathol Lab Med. 1996 Oct;120(10):959-66.
9
Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.小型嗜橘红色类鳞状细胞:胸腔积液细胞学中诊断恶性间皮瘤的一种被低估但有用的形态学特征。
Cancer Cytopathol. 2014 Jan;122(1):70-5. doi: 10.1002/cncy.21345. Epub 2013 Aug 26.
10
MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells.MOC-31有助于鉴别腺癌和反应性间皮细胞。
Cancer. 1999 Dec 25;87(6):390-4. doi: 10.1002/(sici)1097-0142(19991225)87:6<390::aid-cncr10>3.0.co;2-4.

引用本文的文献

1
Single-cell multiplex immunocytochemistry in cell block preparations of metastatic breast cancer confirms sensitivity of GATA-binding protein 3 over gross cystic disease fluid protein 15 and mammaglobin.转移性乳腺癌细胞块制备中的单细胞多重免疫细胞化学证实了GATA结合蛋白3比大囊性病液蛋白15和乳腺珠蛋白更敏感。
Cancer Cytopathol. 2025 Jan;133(1):e22910. doi: 10.1002/cncy.22910. Epub 2024 Oct 8.
2
Effusion cytology of metastatic carcinosarcoma.转移性癌肉瘤的积液细胞学检查
Cytojournal. 2023 Jun 8;20:14. doi: 10.25259/Cytojournal_30_2022. eCollection 2023.
3
Serous fluid: Reactive conditions.

本文引用的文献

1
Cell-blocks and other ancillary studies (including molecular genetic tests and proteomics).细胞块及其他辅助研究(包括分子遗传学检测和蛋白质组学)。
Cytojournal. 2021 Feb 22;18:4. doi: 10.25259/Cytojournal_3_2021. eCollection 2021.
2
Cell-blocks and immunohistochemistry.细胞块与免疫组织化学。
Cytojournal. 2021 Jan 30;18:2. doi: 10.25259/Cytojournal_83_2020. eCollection 2021.
3
CellBlockistry: Chemistry and art of cell-block making - A detailed review of various historical options with recent advances.细胞块制作技术:细胞块制作的化学与艺术——对各种历史方法及最新进展的详细综述
浆液性液体:反应性情况。
Cytojournal. 2022 Mar 19;19:14. doi: 10.25259/CMAS_02_06_2021. eCollection 2022.
4
Serous cavity metastasis: Evaluation of unknown primary.浆膜腔转移:原发灶不明的评估。
Cytojournal. 2022 Mar 19;19:16. doi: 10.25259/CMAS_02_11_2021. eCollection 2022.
5
Mesothelioma.间皮瘤
Cytojournal. 2022 Feb 28;19:10. doi: 10.25259/CMAS_02_08_2021. eCollection 2022.
Cytojournal. 2019 Jun 28;16:12. doi: 10.4103/cytojournal.cytojournal_20_19. eCollection 2019.
4
Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas.甲基硫腺苷磷酸化酶与 BAP1 免疫组化、CDKN2A 和 NF2 荧光原位杂交在区分反应性间皮增生与上皮样恶性间皮瘤中的应用。
Arch Pathol Lab Med. 2018 Dec;142(12):1549-1553. doi: 10.5858/arpa.2018-0273-OA. Epub 2018 Jul 30.
5
Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site.免疫组织化学在原发部位不明转移性癌诊断中的应用
Cancers (Basel). 2018 Apr 5;10(4):108. doi: 10.3390/cancers10040108.
6
Diagnostic value of D2-40 immunostaining for malignant mesothelioma: a meta-analysis.D2-40免疫染色对恶性间皮瘤的诊断价值:一项荟萃分析。
Oncotarget. 2017 Jul 6;8(38):64407-64416. doi: 10.18632/oncotarget.19041. eCollection 2017 Sep 8.
7
From rabbit antibody repertoires to rabbit monoclonal antibodies.从兔抗体库到兔单克隆抗体。
Exp Mol Med. 2017 Mar 24;49(3):e305. doi: 10.1038/emm.2017.23.
8
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.恶性胸膜间皮瘤的全面基因组分析鉴定出复发性突变、基因融合和剪接改变。
Nat Genet. 2016 Apr;48(4):407-16. doi: 10.1038/ng.3520. Epub 2016 Feb 29.
9
Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions.Claudin 4在浆膜腔积液细胞学诊断中的应用价值。
Diagn Cytopathol. 2011 May;39(5):313-7. doi: 10.1002/dc.21380.
10
The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions.免疫组织化学在细胞学渗出液中鉴别反应性间皮细胞与恶性间皮瘤。
Cancer Cytopathol. 2010 Apr 25;118(2):90-6. doi: 10.1002/cncy.20071.